A case of erythrodermic psoriasis in which adalimumab injection sites are preserved.

Ozcan, Ilknur; Karadag, Ayse Serap; Ceren, Eylem; Demirci, Busra; Cebeci, Filiz

Ozcan, Ilknur; Karadag, Ayse Serap; Ceren, Eylem; Demirci, Busra; Cebeci, Filiz.

Afiliación

Ozcan I; Department of Dermatology, Istanbul Medeniyet University School of Medicine Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
Karadag AS; Department of Dermatology, Memorial Atasehir Hospital, Istanbul, Turkey.
Ceren E; Department of Dermatology, Health Science University, Fatih Sultan Mehmet Hospital, Istanbul, Turkey.
Demirci B; Department of Dermatology, Istanbul Medeniyet University School of Medicine Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.
Cebeci F; Department of Dermatology, Istanbul Medeniyet University School of Medicine Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, Turkey.

Dermatol Ther ; 34(2): e14865, 2021 03.

Article en En | MEDLINE | ID: mdl-33569858

Asunto(s)

Dermatitis Exfoliativa; Psoriasis; Adalimumab/efectos adversos; Adalimumab/uso terapéutico; Dermatitis Exfoliativa/inducido químicamente; Dermatitis Exfoliativa/diagnóstico; Humanos; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psoriasis / Dermatitis Exfoliativa Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google